Disappointing to close on the day's low.
Apart from the relationship with the US Advisors, a deal with Adheris hasn't been mentioned in previous announcement, so this comes as a surprise.
What has been published a number of times is PDX going live in April.
The next few months look busy. If they can turn these agreements into just 10% of the annual revenue numbers they're predicting, then H1FY20 looks to be where we see a step change in customer numbers and big pharma programs.
March - Adheris
April/May - PDX Inc
June/July - Zuellig
Disappointing to close on the day's low. Apart from the...
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MDR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
28.5¢ |
Change
-0.005(1.72%) |
Mkt cap ! $215.0M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 29.5¢ | 27.5¢ | $196.5K | 688.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 66010 | 28.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 14888 | 4 |
View Market Depth
| Last trade - 15.00pm 15/11/2024 (20 minute delay) ? |
| MDR (ASX) Chart |
